NCT00457808View on ClinicalTrials.gov

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

March 31, 2006

Conditions
Tuberous SclerosisLymphangioleiomyomatosis
Interventions
DRUG

Rapamycin, sirolimus

Trial Locations (1)

45229-3039

Cincinnati Childrens Hospital Medical Center, Cincinnati

All Listed Sponsors
collaborator

The LAM Foundation

OTHER

collaborator

Tuberous Sclerosis Alliance

OTHER

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT00457808 - Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM | Biotech Hunter | Biotech Hunter